Association of Attention-Deficit/Hyperactivity Disorder Diagnosis With Adolescent Quality of Life.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
03 10 2022
03 10 2022
Historique:
entrez:
13
10
2022
pubmed:
14
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
Appropriate diagnosis of attention-deficit/hyperactivity disorder (ADHD) can improve some short-term outcomes in children and adolescents, but little is known about the association of a diagnosis with their quality of life (QOL). To compare QOL in adolescents with and without an ADHD diagnosis. This cohort study followed an emulated target trial design using prospective, observational data from the Longitudinal Study of Australian Children, a representative, population-based prospective cohort study with biennial data collection from 2006 to 2018 with 8 years of follow-up (ages 6-7 to 14-15 years). Propensity score matching was used to ensure children with and without ADHD diagnosis were well matched on a wide range of variables, including hyperactive/inattentive (H/I) behaviors. Eligible children were born in 1999 to 2000 or 2003 to 2004 and did not have a previous ADHD diagnosis. All incident ADHD cases were matched with controls. Data were analyzed from July 2021 to January 2022. Incident parent-reported ADHD diagnosis at age 6 to 7, 8 to 9, 10 to 11, 12 to 13, or 14 to 15. Quality of life at age 14 to 15 was measured with Child Health Utility 9D (CHU9D) and 8 other prespecified, self-reported measures mapped to the World Health Organization's QOL domains. Pooled regression models were fitted for each outcome, with 95% CIs and P values calculated using bootstrapping to account for matching and repeat observations. Of 8643 eligible children, a total of 393 adolescents had an ADHD diagnosis (284 [72.2%] boys; mean [SD] age, 10.03 [0.30] years; mean [SD] H/I Strengths and Difficulties Questionnaire score, 5.05 [2.29]) and were age-, sex-, and H/I score-matched with 393 adolescents without ADHD diagnosis at time zero. Compared with adolescents without diagnosis, those with an ADHD diagnosis reported similar QOL on CHU9D (mean difference, -0.03; 95% CI, -0.07 to 0.01; P = .10), general health (mean difference, 0.11; 95% CI, -0.04 to 0.27; P = .15), happiness (mean difference, -0.18; 95% CI, -0.37 to 0.00; P = .05), and peer trust (mean difference, 0.65; 95% CI, 0.00 to 1.30; P = .05). Diagnosed adolescents had worse psychological sense of school membership (mean difference, -2.58; 95% CI, -1.13 to -4.06; P < .001), academic self-concept (mean difference, -0.14; 95% CI, -0.02 to -0.26; P = .02), and self-efficacy (mean difference, -0.20; 95% CI, -0.05 to -0.33; P = .007); displayed more negative social behaviors (mean difference, 1.56; 95% CI, 0.55 to 2.66; P = .002); and were more likely to harm themselves (odds ratio, 2.53; 95% CI, 1.49 to 4.37; P < .001) than adolescents without diagnosis. In this cohort study, ADHD diagnosis was not associated with any self-reported improvements in adolescents' QOL compared with adolescents with similar levels of H/I behaviors but no ADHD diagnosis. ADHD diagnosis was associated with worse scores in some outcomes, including significantly increased risk of self-harm. A large, randomized clinical trial with long-term follow-up is needed.
Identifiants
pubmed: 36227598
pii: 2797259
doi: 10.1001/jamanetworkopen.2022.36364
pmc: PMC9561944
doi:
Types de publication
Journal Article
Observational Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2236364Références
J Child Adolesc Psychopharmacol. 2020 Apr;30(3):159-165
pubmed: 31880479
Health Qual Life Outcomes. 2021 Dec 20;19(1):270
pubmed: 34930314
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
J Atten Disord. 2022 Jan;26(2):282-295
pubmed: 33317376
Eur Child Adolesc Psychiatry. 2010 Feb;19(2):83-105
pubmed: 19633992
Soc Sci Res. 2017 Jan;61:251-265
pubmed: 27886732
Pediatrics. 2020 Nov;146(5):
pubmed: 33023991
Pediatrics. 2012 Jul;130(1):e53-62
pubmed: 22732167
J Psychiatr Res. 2020 Apr;123:21-30
pubmed: 32014701
Eur Child Adolesc Psychiatry. 2006 Dec;15 Suppl 1:I4-14
pubmed: 17177015
N Engl J Med. 2021 Oct 7;385(15):1345-1348
pubmed: 34596980
BMC Pediatr. 2020 Jul 3;20(1):329
pubmed: 32620157
Atten Defic Hyperact Disord. 2017 Mar;9(1):11-29
pubmed: 28005216
BMC Med. 2012 Sep 04;10:99
pubmed: 22947230
Eur Child Adolesc Psychiatry. 2018 Feb;27(2):149-158
pubmed: 28733915
Front Public Health. 2021 Dec 22;9:725877
pubmed: 35004561
Eur Child Adolesc Psychiatry. 2017 Nov;26(11):1283-1307
pubmed: 28429134
J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):400-403
pubmed: 19242383
J Psychiatr Pract. 2014 May;20(3):169-77
pubmed: 24847990
Am J Epidemiol. 2016 Apr 15;183(8):758-64
pubmed: 26994063
JAMA Netw Open. 2021 Apr 1;4(4):e215335
pubmed: 33843998
J Consult Clin Psychol. 2012 Feb;80(1):128-38
pubmed: 22201328
Qual Life Res. 2012 May;21(4):717-25
pubmed: 21837445
Eur Child Adolesc Psychiatry. 2004;13 Suppl 2:II3-10
pubmed: 15243780